ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Teriparatide API Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-8Y14451
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Teriparatide API Market Research Report 2023
BUY CHAPTERS

Global Teriparatide API Market Research Report 2025

Code: QYRE-Auto-8Y14451
Report
June 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gedeon Richter
Intas Pharmaceuticals
Rochem International
Suzhou Tianma Pharmaceutical Group
Shenzhen Jianyuan Pharmaceutical Technology
Xinlitai (Suzhou) Pharmaceuticals
Shanghai United Cell Bioengineering
Chengdu Shengnuo Biopharmaceuticals
Zhejiang Paipeptide Biopharmaceuticals

Teriparatide API Market Size

The global market for Teriparatide API was valued at US$ 1206 million in the year 2024 and is projected to reach a revised size of US$ 2130 million by 2031, growing at a CAGR of 8.5% during the forecast period.

Teriparatide API Market

Teriparatide API Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Teriparatide API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Teriparatide is a recombinant human parathyroid hormone (PTH) analogue. Its chemical essence is the 1-34 amino acid fragment of human parathyroid hormone PTH, and it belongs to the class of synthetic polypeptide hormones. It is obtained through genetic recombination technology and is the biologically active N-terminal region of endogenous parathyroid hormone. It can specifically bind to PTH receptors, preferentially stimulate osteoblast activity rather than osteoclast activity, promote new bone formation on the surface of trabecular and cortical bones, thereby increasing bone density, improving bone microstructure and reducing the risk of fractures. As the world's first drug to promote bone formation, teriparatide API must meet strict quality standards, including parameters such as purity, impurity content and stability, to ensure its safety and effectiveness in preparations. It is mainly used clinically to treat postmenopausal osteoporosis with a high risk of fractures, male osteoporosis and glucocorticoid osteoporosis.
Teriparatide API is currently in a development stage with fierce competition between original and generic drugs and accelerated technological iteration. In terms of original drugs, Eli Lilly has long dominated the global market, but generic drugs have risen rapidly after the expiration of patents. For example, Chinese local companies such as Borri Pharmaceuticals have seized market share through cost advantages, especially under the promotion of centralized procurement policies, price competition is fierce; in terms of technology, dosage form innovation has become the key, long-acting preparations (such as Xinlitai weekly powder injection) and prefilled injection pens (Liankang Bio's second-generation water injection) have gradually entered the clinic, and at the same time, the semi-weekly powder injection developed by Asahi Kasei in Japan has become a hit product due to its high compliance. The future trend focuses on the development of long-acting and oral dosage forms, penetration into emerging markets and expansion of indications, while also responding to the dual challenges of centralized procurement policies and alternative therapies.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Teriparatide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Teriparatide API.
The Teriparatide API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Teriparatide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Teriparatide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Teriparatide API Market Report

Report Metric Details
Report Name Teriparatide API Market
Accounted market size in year US$ 1206 million
Forecasted market size in 2031 US$ 2130 million
CAGR 8.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Long-acting Preparations
  • Pre-filled Injection Pens
  • Half-week Powder Injections
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gedeon Richter, Intas Pharmaceuticals, Rochem International, Shenzhen Jianyuan Pharmaceutical Technology, Xinlitai (Suzhou) Pharmaceuticals, Shanghai United Cell Bioengineering, Chengdu Shengnuo Biopharmaceuticals, Zhejiang Paipeptide Biopharmaceuticals, Suzhou Tianma Pharmaceutical Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Teriparatide API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Teriparatide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Teriparatide API Market growing?

Ans: The Teriparatide API Market witnessing a CAGR of 8.5% during the forecast period 2025-2031.

What is the Teriparatide API Market size in 2031?

Ans: The Teriparatide API Market size in 2031 will be US$ 2130 million.

Who are the main players in the Teriparatide API Market report?

Ans: The main players in the Teriparatide API Market are Gedeon Richter, Intas Pharmaceuticals, Rochem International, Shenzhen Jianyuan Pharmaceutical Technology, Xinlitai (Suzhou) Pharmaceuticals, Shanghai United Cell Bioengineering, Chengdu Shengnuo Biopharmaceuticals, Zhejiang Paipeptide Biopharmaceuticals, Suzhou Tianma Pharmaceutical Group

What are the Application segmentation covered in the Teriparatide API Market report?

Ans: The Applications covered in the Teriparatide API Market report are Osteoporosis Treatment, Laboratory Research

What are the Type segmentation covered in the Teriparatide API Market report?

Ans: The Types covered in the Teriparatide API Market report are Long-acting Preparations, Pre-filled Injection Pens, Half-week Powder Injections

Recommended Reports

Active Pharmaceutical Ingredients

Osteoporosis & Bone Drugs

API Market Segments

1 Teriparatide API Market Overview
1.1 Product Definition
1.2 Teriparatide API by Type
1.2.1 Global Teriparatide API Market Value Comparison by Type (2024 VS 2031)
1.2.2 Long-acting Preparations
1.2.3 Pre-filled Injection Pens
1.2.4 Half-week Powder Injections
1.3 Teriparatide API by Application
1.3.1 Global Teriparatide API Market Value by Application (2024 VS 2031)
1.3.2 Osteoporosis Treatment
1.3.3 Laboratory Research
1.4 Global Teriparatide API Market Size Estimates and Forecasts
1.4.1 Global Teriparatide API Revenue 2020-2031
1.4.2 Global Teriparatide API Sales 2020-2031
1.4.3 Global Teriparatide API Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Teriparatide API Market Competition by Manufacturers
2.1 Global Teriparatide API Sales Market Share by Manufacturers (2020-2025)
2.2 Global Teriparatide API Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Teriparatide API Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Teriparatide API, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Teriparatide API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Teriparatide API, Product Type & Application
2.7 Global Key Manufacturers of Teriparatide API, Date of Enter into This Industry
2.8 Global Teriparatide API Market Competitive Situation and Trends
2.8.1 Global Teriparatide API Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Teriparatide API Players Market Share by Revenue
2.8.3 Global Teriparatide API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Teriparatide API Market Scenario by Region
3.1 Global Teriparatide API Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Teriparatide API Sales by Region: 2020-2031
3.2.1 Global Teriparatide API Sales by Region: 2020-2025
3.2.2 Global Teriparatide API Sales by Region: 2026-2031
3.3 Global Teriparatide API Revenue by Region: 2020-2031
3.3.1 Global Teriparatide API Revenue by Region: 2020-2025
3.3.2 Global Teriparatide API Revenue by Region: 2026-2031
3.4 North America Teriparatide API Market Facts & Figures by Country
3.4.1 North America Teriparatide API Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Teriparatide API Sales by Country (2020-2031)
3.4.3 North America Teriparatide API Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Teriparatide API Market Facts & Figures by Country
3.5.1 Europe Teriparatide API Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Teriparatide API Sales by Country (2020-2031)
3.5.3 Europe Teriparatide API Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Teriparatide API Market Facts & Figures by Region
3.6.1 Asia Pacific Teriparatide API Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Teriparatide API Sales by Region (2020-2031)
3.6.3 Asia Pacific Teriparatide API Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Teriparatide API Market Facts & Figures by Country
3.7.1 Latin America Teriparatide API Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Teriparatide API Sales by Country (2020-2031)
3.7.3 Latin America Teriparatide API Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Teriparatide API Market Facts & Figures by Country
3.8.1 Middle East and Africa Teriparatide API Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Teriparatide API Sales by Country (2020-2031)
3.8.3 Middle East and Africa Teriparatide API Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Teriparatide API Sales by Type (2020-2031)
4.1.1 Global Teriparatide API Sales by Type (2020-2025)
4.1.2 Global Teriparatide API Sales by Type (2026-2031)
4.1.3 Global Teriparatide API Sales Market Share by Type (2020-2031)
4.2 Global Teriparatide API Revenue by Type (2020-2031)
4.2.1 Global Teriparatide API Revenue by Type (2020-2025)
4.2.2 Global Teriparatide API Revenue by Type (2026-2031)
4.2.3 Global Teriparatide API Revenue Market Share by Type (2020-2031)
4.3 Global Teriparatide API Price by Type (2020-2031)
5 Segment by Application
5.1 Global Teriparatide API Sales by Application (2020-2031)
5.1.1 Global Teriparatide API Sales by Application (2020-2025)
5.1.2 Global Teriparatide API Sales by Application (2026-2031)
5.1.3 Global Teriparatide API Sales Market Share by Application (2020-2031)
5.2 Global Teriparatide API Revenue by Application (2020-2031)
5.2.1 Global Teriparatide API Revenue by Application (2020-2025)
5.2.2 Global Teriparatide API Revenue by Application (2026-2031)
5.2.3 Global Teriparatide API Revenue Market Share by Application (2020-2031)
5.3 Global Teriparatide API Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gedeon Richter
6.1.1 Gedeon Richter Company Information
6.1.2 Gedeon Richter Description and Business Overview
6.1.3 Gedeon Richter Teriparatide API Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gedeon Richter Teriparatide API Product Portfolio
6.1.5 Gedeon Richter Recent Developments/Updates
6.2 Intas Pharmaceuticals
6.2.1 Intas Pharmaceuticals Company Information
6.2.2 Intas Pharmaceuticals Description and Business Overview
6.2.3 Intas Pharmaceuticals Teriparatide API Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Intas Pharmaceuticals Teriparatide API Product Portfolio
6.2.5 Intas Pharmaceuticals Recent Developments/Updates
6.3 Rochem International
6.3.1 Rochem International Company Information
6.3.2 Rochem International Description and Business Overview
6.3.3 Rochem International Teriparatide API Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Rochem International Teriparatide API Product Portfolio
6.3.5 Rochem International Recent Developments/Updates
6.4 Shenzhen Jianyuan Pharmaceutical Technology
6.4.1 Shenzhen Jianyuan Pharmaceutical Technology Company Information
6.4.2 Shenzhen Jianyuan Pharmaceutical Technology Description and Business Overview
6.4.3 Shenzhen Jianyuan Pharmaceutical Technology Teriparatide API Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shenzhen Jianyuan Pharmaceutical Technology Teriparatide API Product Portfolio
6.4.5 Shenzhen Jianyuan Pharmaceutical Technology Recent Developments/Updates
6.5 Xinlitai (Suzhou) Pharmaceuticals
6.5.1 Xinlitai (Suzhou) Pharmaceuticals Company Information
6.5.2 Xinlitai (Suzhou) Pharmaceuticals Description and Business Overview
6.5.3 Xinlitai (Suzhou) Pharmaceuticals Teriparatide API Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Xinlitai (Suzhou) Pharmaceuticals Teriparatide API Product Portfolio
6.5.5 Xinlitai (Suzhou) Pharmaceuticals Recent Developments/Updates
6.6 Shanghai United Cell Bioengineering
6.6.1 Shanghai United Cell Bioengineering Company Information
6.6.2 Shanghai United Cell Bioengineering Description and Business Overview
6.6.3 Shanghai United Cell Bioengineering Teriparatide API Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shanghai United Cell Bioengineering Teriparatide API Product Portfolio
6.6.5 Shanghai United Cell Bioengineering Recent Developments/Updates
6.7 Chengdu Shengnuo Biopharmaceuticals
6.7.1 Chengdu Shengnuo Biopharmaceuticals Company Information
6.7.2 Chengdu Shengnuo Biopharmaceuticals Description and Business Overview
6.7.3 Chengdu Shengnuo Biopharmaceuticals Teriparatide API Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chengdu Shengnuo Biopharmaceuticals Teriparatide API Product Portfolio
6.7.5 Chengdu Shengnuo Biopharmaceuticals Recent Developments/Updates
6.8 Zhejiang Paipeptide Biopharmaceuticals
6.8.1 Zhejiang Paipeptide Biopharmaceuticals Company Information
6.8.2 Zhejiang Paipeptide Biopharmaceuticals Description and Business Overview
6.8.3 Zhejiang Paipeptide Biopharmaceuticals Teriparatide API Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Zhejiang Paipeptide Biopharmaceuticals Teriparatide API Product Portfolio
6.8.5 Zhejiang Paipeptide Biopharmaceuticals Recent Developments/Updates
6.9 Suzhou Tianma Pharmaceutical Group
6.9.1 Suzhou Tianma Pharmaceutical Group Company Information
6.9.2 Suzhou Tianma Pharmaceutical Group Description and Business Overview
6.9.3 Suzhou Tianma Pharmaceutical Group Teriparatide API Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Suzhou Tianma Pharmaceutical Group Teriparatide API Product Portfolio
6.9.5 Suzhou Tianma Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Teriparatide API Industry Chain Analysis
7.2 Teriparatide API Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Teriparatide API Production Mode & Process Analysis
7.4 Teriparatide API Sales and Marketing
7.4.1 Teriparatide API Sales Channels
7.4.2 Teriparatide API Distributors
7.5 Teriparatide API Customer Analysis
8 Teriparatide API Market Dynamics
8.1 Teriparatide API Industry Trends
8.2 Teriparatide API Market Drivers
8.3 Teriparatide API Market Challenges
8.4 Teriparatide API Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Gedeon Richter
Intas Pharmaceuticals
Rochem International
Suzhou Tianma Pharmaceutical Group
Shenzhen Jianyuan Pharmaceutical Technology
Xinlitai (Suzhou) Pharmaceuticals
Shanghai United Cell Bioengineering
Chengdu Shengnuo Biopharmaceuticals
Zhejiang Paipeptide Biopharmaceuticals
List of Tables
 Table 1. Global Teriparatide API Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Teriparatide API Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Teriparatide API Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Teriparatide API Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Teriparatide API Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Teriparatide API Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Teriparatide API Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Teriparatide API Average Price (US$/kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Teriparatide API, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Teriparatide API, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Teriparatide API, Product Type & Application
 Table 12. Global Key Manufacturers of Teriparatide API, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Teriparatide API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Teriparatide API as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Teriparatide API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Teriparatide API Sales by Region (2020-2025) & (Tons)
 Table 18. Global Teriparatide API Sales Market Share by Region (2020-2025)
 Table 19. Global Teriparatide API Sales by Region (2026-2031) & (Tons)
 Table 20. Global Teriparatide API Sales Market Share by Region (2026-2031)
 Table 21. Global Teriparatide API Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Teriparatide API Revenue Market Share by Region (2020-2025)
 Table 23. Global Teriparatide API Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Teriparatide API Revenue Market Share by Region (2026-2031)
 Table 25. North America Teriparatide API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Teriparatide API Sales by Country (2020-2025) & (Tons)
 Table 27. North America Teriparatide API Sales by Country (2026-2031) & (Tons)
 Table 28. North America Teriparatide API Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Teriparatide API Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Teriparatide API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Teriparatide API Sales by Country (2020-2025) & (Tons)
 Table 32. Europe Teriparatide API Sales by Country (2026-2031) & (Tons)
 Table 33. Europe Teriparatide API Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Teriparatide API Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Teriparatide API Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Teriparatide API Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific Teriparatide API Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific Teriparatide API Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Teriparatide API Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Teriparatide API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Teriparatide API Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America Teriparatide API Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America Teriparatide API Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Teriparatide API Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Teriparatide API Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Teriparatide API Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa Teriparatide API Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa Teriparatide API Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Teriparatide API Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Teriparatide API Sales (Tons) by Type (2020-2025)
 Table 51. Global Teriparatide API Sales (Tons) by Type (2026-2031)
 Table 52. Global Teriparatide API Sales Market Share by Type (2020-2025)
 Table 53. Global Teriparatide API Sales Market Share by Type (2026-2031)
 Table 54. Global Teriparatide API Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Teriparatide API Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Teriparatide API Revenue Market Share by Type (2020-2025)
 Table 57. Global Teriparatide API Revenue Market Share by Type (2026-2031)
 Table 58. Global Teriparatide API Price (US$/kg) by Type (2020-2025)
 Table 59. Global Teriparatide API Price (US$/kg) by Type (2026-2031)
 Table 60. Global Teriparatide API Sales (Tons) by Application (2020-2025)
 Table 61. Global Teriparatide API Sales (Tons) by Application (2026-2031)
 Table 62. Global Teriparatide API Sales Market Share by Application (2020-2025)
 Table 63. Global Teriparatide API Sales Market Share by Application (2026-2031)
 Table 64. Global Teriparatide API Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Teriparatide API Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Teriparatide API Revenue Market Share by Application (2020-2025)
 Table 67. Global Teriparatide API Revenue Market Share by Application (2026-2031)
 Table 68. Global Teriparatide API Price (US$/kg) by Application (2020-2025)
 Table 69. Global Teriparatide API Price (US$/kg) by Application (2026-2031)
 Table 70. Gedeon Richter Company Information
 Table 71. Gedeon Richter Description and Business Overview
 Table 72. Gedeon Richter Teriparatide API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 73. Gedeon Richter Teriparatide API Product
 Table 74. Gedeon Richter Recent Developments/Updates
 Table 75. Intas Pharmaceuticals Company Information
 Table 76. Intas Pharmaceuticals Description and Business Overview
 Table 77. Intas Pharmaceuticals Teriparatide API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 78. Intas Pharmaceuticals Teriparatide API Product
 Table 79. Intas Pharmaceuticals Recent Developments/Updates
 Table 80. Rochem International Company Information
 Table 81. Rochem International Description and Business Overview
 Table 82. Rochem International Teriparatide API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 83. Rochem International Teriparatide API Product
 Table 84. Rochem International Recent Developments/Updates
 Table 85. Shenzhen Jianyuan Pharmaceutical Technology Company Information
 Table 86. Shenzhen Jianyuan Pharmaceutical Technology Description and Business Overview
 Table 87. Shenzhen Jianyuan Pharmaceutical Technology Teriparatide API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 88. Shenzhen Jianyuan Pharmaceutical Technology Teriparatide API Product
 Table 89. Shenzhen Jianyuan Pharmaceutical Technology Recent Developments/Updates
 Table 90. Xinlitai (Suzhou) Pharmaceuticals Company Information
 Table 91. Xinlitai (Suzhou) Pharmaceuticals Description and Business Overview
 Table 92. Xinlitai (Suzhou) Pharmaceuticals Teriparatide API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 93. Xinlitai (Suzhou) Pharmaceuticals Teriparatide API Product
 Table 94. Xinlitai (Suzhou) Pharmaceuticals Recent Developments/Updates
 Table 95. Shanghai United Cell Bioengineering Company Information
 Table 96. Shanghai United Cell Bioengineering Description and Business Overview
 Table 97. Shanghai United Cell Bioengineering Teriparatide API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 98. Shanghai United Cell Bioengineering Teriparatide API Product
 Table 99. Shanghai United Cell Bioengineering Recent Developments/Updates
 Table 100. Chengdu Shengnuo Biopharmaceuticals Company Information
 Table 101. Chengdu Shengnuo Biopharmaceuticals Description and Business Overview
 Table 102. Chengdu Shengnuo Biopharmaceuticals Teriparatide API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 103. Chengdu Shengnuo Biopharmaceuticals Teriparatide API Product
 Table 104. Chengdu Shengnuo Biopharmaceuticals Recent Developments/Updates
 Table 105. Zhejiang Paipeptide Biopharmaceuticals Company Information
 Table 106. Zhejiang Paipeptide Biopharmaceuticals Description and Business Overview
 Table 107. Zhejiang Paipeptide Biopharmaceuticals Teriparatide API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 108. Zhejiang Paipeptide Biopharmaceuticals Teriparatide API Product
 Table 109. Zhejiang Paipeptide Biopharmaceuticals Recent Developments/Updates
 Table 110. Suzhou Tianma Pharmaceutical Group Company Information
 Table 111. Suzhou Tianma Pharmaceutical Group Description and Business Overview
 Table 112. Suzhou Tianma Pharmaceutical Group Teriparatide API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
 Table 113. Suzhou Tianma Pharmaceutical Group Teriparatide API Product
 Table 114. Suzhou Tianma Pharmaceutical Group Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Teriparatide API Distributors List
 Table 118. Teriparatide API Customers List
 Table 119. Teriparatide API Market Trends
 Table 120. Teriparatide API Market Drivers
 Table 121. Teriparatide API Market Challenges
 Table 122. Teriparatide API Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Teriparatide API
 Figure 2. Global Teriparatide API Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Teriparatide API Market Share by Type: 2024 & 2031
 Figure 4. Long-acting Preparations Product Picture
 Figure 5. Pre-filled Injection Pens Product Picture
 Figure 6. Half-week Powder Injections Product Picture
 Figure 7. Global Teriparatide API Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Teriparatide API Market Share by Application: 2024 & 2031
 Figure 9. Osteoporosis Treatment
 Figure 10. Laboratory Research
 Figure 11. Global Teriparatide API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Teriparatide API Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Teriparatide API Sales (2020-2031) & (Tons)
 Figure 14. Global Teriparatide API Average Price (US$/kg) & (2020-2031)
 Figure 15. Teriparatide API Report Years Considered
 Figure 16. Teriparatide API Sales Share by Manufacturers in 2024
 Figure 17. Global Teriparatide API Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Teriparatide API Players: Market Share by Revenue in Teriparatide API in 2024
 Figure 19. Teriparatide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Teriparatide API Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Teriparatide API Sales Market Share by Country (2020-2031)
 Figure 22. North America Teriparatide API Revenue Market Share by Country (2020-2031)
 Figure 23. United States Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Teriparatide API Sales Market Share by Country (2020-2031)
 Figure 26. Europe Teriparatide API Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Teriparatide API Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Teriparatide API Revenue Market Share by Region (2020-2031)
 Figure 34. China Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Teriparatide API Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Teriparatide API Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Teriparatide API Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Teriparatide API Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Teriparatide API Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Teriparatide API by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Teriparatide API by Type (2020-2031)
 Figure 53. Global Teriparatide API Price (US$/kg) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Teriparatide API by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Teriparatide API by Application (2020-2031)
 Figure 56. Global Teriparatide API Price (US$/kg) by Application (2020-2031)
 Figure 57. Teriparatide API Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Terbutaline Sulfate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Medium Chain Triglyceride API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Api Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chemical API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Epalrestat API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Aprepitant API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lipoic Acid API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
API Derivatives Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Everolimus API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Psychiatric API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Miglustat API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Terazosin Hydrochloride API Market Research Report 2025
Sartans API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Imipenem API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Tenoxicam API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
DTaP Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pitavastatin Calcium API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Policresulen API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti infective API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Testosterone API Market Research Report 2025

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions